Gilead’s tactics may have resulted in higher drug prices but that is just one of the many issues at play here, as the article details. I have written about Gilead issues elsewhere: www.nytimes.com/2019/10/04/h...
F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Everyone (Published 2019)www.nytimes.com